Clinical Trials List
Protocol NumberOBI-822-003
Completed
2017-04-01 - 2019-12-31
Phase II
Terminated2
-
Trial Applicant
OBI PHARMA, INC.
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
50 participants
